Literature DB >> 7490274

Evidence for a short form of alpha 1(IV) as a major polypeptide in bovine lens capsule.

M Iwata1, Y Imamura, T Sasaki, T Hayashi.   

Abstract

The extracts from bovine lens capsule with acetic acid contained, after reduction, three major collagenous polypeptides with M(r) = 180k, 175k, and 160k, which were specifically immuno-stained with anti-type IV collagen polyclonal antibody. The biochemical properties of 180k and 160k polypeptides were akin and were distinct from that of 175k polypeptide [J. Biochem. (1993) 114,358-362]. In the present study, evidence that the 160k and 180k polypeptides from bovine lens capsule both originated from alpha 1(IV) was obtained on the basis of reactivity with a monoclonal antibody that recognizes alpha 1(IV) chain at the collagenous sequence contained in [KGEPGLPGRGFPGFP]. The epitope-bearing sequence was identified from the following three experiments. Pepsin-solubilized polypeptides from human placenta were purified by affinity chromatography on the antibody-coupled column and sequenced. The restriction map of the clones positively reactive with the monoclonal antibody from human placenta cDNA library was superimposed on that of human alpha 1(IV) cDNA at a specific region. Synthetic peptides corresponding to the sequence were assayed for inhibitory activity against the reaction between epitope-bearing pepsin fragments and the antibody. The 180k and 160k polypeptides showed similar intensities in protein staining as well as in immuno-staining with the monoclonal antibody. In contrast, the 175k polypeptide did not react with the monoclonal antibody, indicating that it is a genetically distinct type IV collagen chain, presumably alpha 2(IV) from its abundance. The 160k, a major type IV collagen polypeptide, is a short form of alpha 1(IV) present as a tissue form in bovine lens capsule.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7490274     DOI: 10.1093/oxfordjournals.jbchem.a124858

Source DB:  PubMed          Journal:  J Biochem        ISSN: 0021-924X            Impact factor:   3.387


  5 in total

1.  Activin A binds to perlecan through its pro-region that has heparin/heparan sulfate binding activity.

Authors:  Shaoliang Li; Chisei Shimono; Naoko Norioka; Itsuko Nakano; Tetsuo Okubo; Yoshiko Yagi; Maria Hayashi; Yuya Sato; Hitomi Fujisaki; Shunji Hattori; Nobuo Sugiura; Koji Kimata; Kiyotoshi Sekiguchi
Journal:  J Biol Chem       Date:  2010-09-15       Impact factor: 5.157

2.  Mice deficient for the secreted glycoprotein SPARC/osteonectin/BM40 develop normally but show severe age-onset cataract formation and disruption of the lens.

Authors:  D T Gilmour; G J Lyon; M B Carlton; J R Sanes; J M Cunningham; J R Anderson; B L Hogan; M J Evans; W H Colledge
Journal:  EMBO J       Date:  1998-04-01       Impact factor: 11.598

3.  Preparation and partial characterization of monoclonal antibodies specific for the nascent non-triple helical form of the type IV collagen alpha 1 chain.

Authors:  Makoto Morita; Hidemitsu Sugihara; Kazuhiro Tokunaka; Arihiro Tomura; Kan Saiga; Takamichi Sato; Yasutada Imamura; Toshihiko Hayashi
Journal:  Biochem Biophys Rep       Date:  2016-12-08

4.  Basement membrane-like structures containing NTH α1(IV) are formed around the endothelial cell network in a novel in vitro angiogenesis model.

Authors:  Yongchol Shin; Akane Moriya; Yuta Tohnishi; Takafumi Watanabe; Yasutada Imamura
Journal:  Am J Physiol Cell Physiol       Date:  2019-06-12       Impact factor: 4.249

5.  Non-Triple Helical Form of Type IV Collagen α1 Chain.

Authors:  Hiroaki Sugiyama; Kazuhiro Tokunaka; Toshihiko Hayashi; Yasutada Imamura; Makoto Morita; Masayuki Yamato
Journal:  Heliyon       Date:  2015-12-09
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.